|
|
|
Insider
Information: |
Middleton Fred A |
Relationship: |
|
City: |
San Mateo |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
593,164 |
|
Indirect Shares
|
7,544,680 |
|
|
Direct
Value |
$2,851,173 |
|
|
Indirect Value
|
$5,843,226 |
|
|
Total
Shares |
8,137,844 |
|
|
Total
Value |
$8,694,399 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
9
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
8
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.4%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Stereotaxis Inc |
STXS |
Director |
2018-03-02 |
303,528 |
2018-03-02 |
1,325,167 |
Premium* |
|
Mmrglobal Inc |
MMRF |
Director |
2008-12-09 |
0 |
2006-03-07 |
2,773,091 |
Premium* |
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2013-06-24 |
70,399 |
2013-06-24 |
0 |
Premium* |
|
Endocyte Inc |
ECYT |
Director |
2018-12-21 |
0 |
2018-12-21 |
0 |
Premium* |
|
Chimerix Inc |
CMRX |
Director |
2023-11-17 |
207,523 |
2023-11-17 |
3,407,954 |
Premium* |
|
Calcimedica Ord Shs |
CALC |
|
2024-01-23 |
11,714 |
2024-01-23 |
38,468 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ECYT |
Endocyte Inc |
Director |
|
2018-12-21 |
4 |
D |
$24.00 |
$97,094,808 |
I/I |
(4,045,617) |
0 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-03-11 |
4/A |
S |
$27.86 |
$9,721,775 |
D/D |
(348,951) |
559,453 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-01-24 |
4/A |
S |
$18.93 |
$9,465,000 |
D/D |
(500,000) |
882,562 |
0 |
- |
|
MMRF |
Mmrglobal Inc |
Director |
|
2005-02-07 |
4 |
B |
$7.00 |
$7,999,999 |
I/I |
1,142,857 |
3,182,652 |
2.25 |
- |
|
ECYT |
Endocyte Inc |
Director |
|
2011-02-07 |
4 |
B |
$6.00 |
$4,999,998 |
I/I |
833,333 |
785,417 |
2.1 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-03-18 |
4 |
AS |
$28.19 |
$4,745,234 |
D/D |
(165,411) |
0 |
0 |
- |
|
STXS |
Stereotaxis Inc |
Director |
|
2008-12-29 |
4 |
B |
$4.64 |
$4,696,283 |
I/I |
1,012,130 |
16,270 |
2.25 |
- |
|
ECYT |
Endocyte Inc |
Director |
|
2018-12-21 |
4 |
D |
$24.00 |
$2,723,736 |
D/D |
(113,489) |
0 |
0 |
- |
|
CALC |
Calcimedica Ord Shs |
|
|
2024-01-23 |
4 |
B |
$3.70 |
$2,515,080 |
I/I |
679,384 |
30,292 |
0.01 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-03-19 |
4 |
AS |
$26.95 |
$2,306,831 |
D/D |
(84,589) |
416,083 |
0 |
- |
|
STXS |
Stereotaxis Inc |
Director |
|
2013-08-13 |
4 |
D |
$6.39 |
$2,188,096 |
I/I |
(342,425) |
40,673 |
0 |
- |
|
STXS |
Stereotaxis Inc |
Director |
|
2013-08-13 |
4 |
OE |
$3.36 |
$2,186,080 |
I/I |
650,619 |
54,623 |
0 |
- |
|
ECYT |
Endocyte Inc |
Director |
|
2018-02-28 |
4 |
A |
$4.20 |
$2,100,000 |
I/I |
500,000 |
904,465 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-06-21 |
4 |
AS |
$28.49 |
$2,041,714 |
I/I |
(70,000) |
5,900 |
0 |
- |
|
STXS |
Stereotaxis Inc |
Director |
|
2006-09-27 |
4 |
OE |
$6.53 |
$1,974,691 |
I/I |
278,010 |
153,209 |
0 |
- |
|
STXS |
Stereotaxis Inc |
Director |
|
2008-03-07 |
4 |
B |
$3.90 |
$1,950,000 |
I/I |
500,000 |
6,149 |
2.25 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-06-20 |
4 |
AS |
$28.93 |
$1,912,273 |
I/I |
(66,100) |
30,798 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2011-02-08 |
4 |
B |
$7.00 |
$1,874,999 |
I/I |
267,857 |
184,131 |
2.1 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-06-19 |
4 |
AS |
$29.76 |
$1,440,384 |
I/I |
(48,400) |
96,898 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-06-18 |
4 |
AS |
$29.48 |
$872,608 |
I/I |
(29,600) |
145,298 |
0 |
- |
|
STXS |
Stereotaxis Inc |
Director |
|
2013-08-07 |
4/A |
D |
$10.13 |
$800,007 |
I/I |
(78,974) |
5,335 |
0 |
- |
|
STXS |
Stereotaxis Inc |
Director |
|
2013-08-07 |
4 |
S |
$10.13 |
$800,007 |
I/I |
(78,974) |
5,335 |
0 |
- |
|
STXS |
Stereotaxis Inc |
Director |
|
2013-08-07 |
4 |
OE |
$1.98 |
$799,853 |
I/I |
262,452 |
6,297 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-03-07 |
4/A |
S |
$25.92 |
$662,515 |
D/D |
(25,560) |
1,361,762 |
0 |
- |
|
PCRX |
Pacira Pharmaceuticals, I... |
Director |
|
2013-03-07 |
4/A |
OE |
$2.69 |
$662,373 |
D/D |
79,031 |
1,372,169 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|